Member of the Board since 2011. Associate Professor in Pharmaceutical Science. More than 30 years in management positions, as President of Astra Hässle AB, Executive VP at AstraZeneca, CEO of Biovitrum and Sobi. Chairman of the Boards of Zealand Pharma A/S, Orexo AB and Farma Investment AS. Member of the Boards of Basilea Pharmaceutica Ldt., PledPharma AB, BioInvent AB and the Swedish Heart and Lung Foundation.